Gemtesa urinary retention
WebGEMTESA may cause serious side effects, including the inability to empty your bladder (urinary retention). GEMTESA may increase your chances of not being able to empty your bladder, especially if you have bladder outlet obstruction or take other medicines for treatment of overactive bladder. Tell WebUrinary retention. Urinary retention reported. Risk increased in patients with bladder outlet obstruction and patients taking muscarinic antagonists medications; closely …
Gemtesa urinary retention
Did you know?
WebUrinary Retention. Urinary retention has been reported in patients taking GEMTESA. The risk of urinary retention may be increased in patients with bladder outlet obstruction and also in patients taking muscarinic antagonist medications for the treatment of OAB. Monitor patients for signs and symptoms of urinary retention, particularly in ... WebJun 23, 2024 · These include: Weak urine stream or trouble emptying your bladder. It’s not common, but Gemtesa use may cause urinary retention... Kidney or liver problems. Your liver and kidneys help get rid of Gemtesa after you take a dose. If you have severe...
WebVibegron (applies to Gemtesa) urinary retention Moderate Potential Hazard, Moderate plausibility. Vibegron may increase the risk of urinary retention, particularly in patients with bladder outlet obstruction and in those taking muscarinic antagonist medications to treat overactive bladder (OAB). WebUrinary retention has been reported in patients taking GEMTESA. The risk of urinary retention may be increased in patients with bladder outlet obstruction and also in patients taking muscarinic antagonist medications for the treatment of OAB. Monitor patients for signs and symptoms of urinary retention,
WebApr 26, 2024 · These include: Urinary tract infection (UTI) Headache Nasal congestion, runny nose, and/or sore throat Respiratory tract infection Diarrhea Nausea 6 WebApr 4, 2024 · Generic name: vibegron Brand name: Gemtesa Dosage form: oral tablet Drug class: Urinary antispasmodics Medically reviewed by Nicole France, BPharm. Last updated on May 6, 2024. Uses Before taking Directions Dosage Side effects Interactions FAQ What is vibegron? Vibegron is a type of drug called a beta-3 agonist.
WebJan 7, 2024 · Other adverse reactions reported in <2% of patients treated with GEMTESA included: Gastrointestinal disorders: dry mouth, constipation Investigations: residual …
WebJan 9, 2024 · Learn about the potential side effects of Gemtesa (vibegron). Includes common and rare side effects information for consumers and healthcare professionals. … filmaffinity gladiatorWebMay 2, 2024 · Gemtesa is a selective beta-3 adrenergic agonist that affects the muscles in the bladder. Gemtesa is used in adults to treat the symptoms of overactive bladder. … filmaffinity gomorraWebLearn about Gemtesa (vibegron), potential side effects, proper use and dosing, and popular alternatives. ... Certain foods can irritate the bladder and make your urinary symptoms worse. These foods include alcohol, coffee, carbonated drinks (sodas), spicy foods, and citrus fruits. ... Urinary retention (trouble emptying bladder fully) Hot flush ... ground state of potassiumWebDec 3, 2024 · Urinary retention. Urinary retention is a rare but possible side effect with Gemtesa treatment, according to the drug’s clinical studies . With urinary retention, you are unable to voluntarily or completely empty your bladder. Gemtesa works by relaxing muscles in your bladder, which could make it difficult to urinate. groundstate of the frohlich hamiltonianWebUrinary Retention. Urinary retention has been reported in patients taking GEMTESA. The risk of urinary retention may be increased in patients with bladder outlet obstruction and also in patients taking muscarinic antagonist medications for the treatment of OAB. Monitor patients for signs and symptoms of urinary retention, particularly in ... filmaffinity granizoWebUrinary retention has been reported in patients taking GEMTESA. The risk of urinary retention may be increased in patients with bladder outlet obstruction and also in patients taking muscarinic antagonist medications for the treatment of OAB. Monitor patients for signs and symptoms of urinary retention, particularly in patients ground states for expanding thurston mapsWebFeb 11, 2024 · Urinary retention has been reported in patients taking GEMTESA. The risk of urinary retention may be increased in patients with bladder outlet obstruction and also in patients taking muscarinic antagonist medications for the treatment of OAB. Monitor patients for signs and symptoms of urinary retention, particularly in patients with bladder ... ground state term symbol for sm3+